NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
about
Molecular mechanisms of peritoneal dissemination in gastric cancerGPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.From Neural Crest Development to Cancer and Vice Versa: How p75 and (Pro)neurotrophins Could Act on Cell Migration and Invasion?
P2860
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@ast
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@en
type
label
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@ast
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@en
prefLabel
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@ast
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
@en
P2093
Chie Tanaka
Dai Shimizu
Goro Nakayama
Hideki Takami
Hiroyuki Sugimoto
Kazuhiro Ezaka
Masahiko Koike
Michitaka Fujiwara
Mitsuro Kanda
Naoki Iwata
P2860
P304
P356
10.3892/OL.2016.4120
P577
2016-01-15T00:00:00Z